Drug intelligence / Profile preview

Tetterine

Development stage
Unknown
Lead developer
SSS Company
Modality
Small Molecules
Administration
Topical
01

Overview

Tetterine is an over-the-counter (OTC) topical antifungal ointment developed and manufactured by the S.S.S. Company. The formulation contains 2% miconazole nitrate, a small molecule imidazole antifungal agent. Tetterine is indicated for the treatment of superficial fungal skin infections, specifically athlete's foot (tinea pedis), jock itch (tinea cruris), and ringworm (tinea corporis). Its mechanism of action involves the inhibition of the fungal enzyme lanosterol 14-alpha-demethylase, which is essential for the biosynthesis of ergosterol. The resulting depletion of ergosterol and accumulation of methylated sterol precursors lead to the disruption of fungal cell membrane integrity and inhibition of fungal growth. Marketed since 1883, Tetterine is available in ointment and cream forms and is produced in compliance with FDA cGMP standards.

Brand names
Tetterine
Other names
Tetterine Antifungal Ointment
02

Targets

CYP51A1 (Sterol 14α-demethylase)

Beyond the preview

Go deeper on Tetterine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tetterine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call